GEHC
GE HealthCare Technologies Inc.
NASDAQ: GEHC · HEALTHCARE · MEDICAL DEVICES
$59.49
-13.16% today
Updated 2026-04-29
Market cap
$27.06B
P/E ratio
14.27
P/S ratio
1.31x
EPS (TTM)
$4.17
Dividend yield
—
52W range
$59 – $90
Volume
3.9M
GE HealthCare Technologies Inc. (GEHC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $16.63B | $17.16B | $17.59B | $18.34B | $19.55B | $19.67B | $20.63B |
| Revenue growth (YoY) | — | +3.2% | +2.5% | +4.3% | +6.6% | +0.6% | +4.8% |
| Cost of revenue | $10.09B | $10.40B | $10.41B | $11.16B | $11.63B | $11.47B | $12.38B |
| Gross profit | $6.55B | $6.77B | $7.17B | $7.18B | $7.92B | $8.21B | $8.25B |
| Gross margin | 39.4% | 39.4% | 40.8% | 39.1% | 40.5% | 41.7% | 40.0% |
| R&D | $833.00M | $810.00M | $816.00M | $1.03B | $1.21B | $1.31B | $1.26B |
| SG&A | $3.59B | $3.24B | $3.56B | $3.63B | $4.28B | $4.27B | $4.15B |
| Operating income | $2.12B | $2.72B | $2.79B | $2.52B | $2.44B | $2.63B | $2.76B |
| Operating margin | 12.8% | 15.8% | 15.9% | 13.8% | 12.5% | 13.3% | 13.4% |
| EBITDA | $2.84B | $3.41B | $3.54B | $3.17B | $2.44B | $3.67B | $3.79B |
| EBITDA margin | 17.1% | 19.8% | 20.1% | 17.3% | 12.5% | 18.6% | 18.4% |
| EBIT | $2.18B | $2.78B | $2.92B | $2.53B | $2.44B | $3.09B | $3.21B |
| Interest expense | $88.00M | $66.00M | $40.00M | $86.00M | $542.00M | $505.00M | $450.00M |
| Income tax | $410.00M | $652.00M | $600.00M | $563.00M | $-743.00M | $531.00M | $614.00M |
| Effective tax rate | 21.2% | 4.5% | 21.1% | 22.7% | -31.5% | 21.0% | 22.8% |
| Net income | $1.52B | $13.85B | $2.25B | $1.92B | $3.10B | $1.99B | $2.08B |
| Net income growth (YoY) | — | +808.5% | -83.8% | -14.7% | +62.0% | -35.8% | +4.6% |
| Profit margin | 9.2% | 80.7% | 12.8% | 10.4% | 15.9% | 10.1% | 10.1% |